2024/2101

31.7.2024

COMMISSION IMPLEMENTING REGULATION (EU) 2024/2101

of 30 July 2024

authorising the placing on the market of

Schizochytrium

sp. (CABIO-A-2) oil as a novel food and amending Implementing Regulation (EU) 2017/2470

(Text with EEA relevance)

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Regulation (EU) 2015/2283 of the European Parliament and of the Council of 25 November 2015 on novel foods, amending Regulation (EU) No 1169/2011 of the European Parliament and of the Council and repealing Regulation (EC) No 258/97 of the European Parliament and of the Council and Commission Regulation (EC) No 1852/2001 (1), and in particular Article 12(1) thereof,

Whereas:

(1) Regulation (EU) 2015/2283 provides that only novel foods authorised and included in the Union list of novel foods may be placed on the market within the Union.

(2) Pursuant to Article 8 of Regulation (EU) 2015/2283, Commission Implementing Regulation (EU) 2017/2470 (2) has established a Union list of novel foods.

(3) On 19 March 2021, the company CABIO Biotech (Wuhan) Co., Ltd. (‘the applicant’) submitted an application for an authorisation to the Commission in accordance with Article 10(1) of Regulation (EU) 2015/2283 to place

Schizochytrium

sp. (CABIO-A-2) oil on the Union market as a novel food. The applicant requested for the novel food to be authorised for use in infant formula and follow-on formula as defined in Regulation (EU) No 609/2013 of the European Parliament and of the Council (3). The strain of

Schizochytrium

sp. used by the applicant and concerned by this application is specified as strain CABIO-A-2.

(4) On 12 July 2021, the Commission requested the European Food Safety Authority (‘the Authority’) to carry out an assessment of

Schizochytrium

sp. (CABIO-A-2) oil as a novel food.

(5) On 26 October 2023, the Authority adopted its scientific opinion on the ‘Safety of oil from

Schizochytrium

sp. (strain CABIO-A-2) for use in infant and follow-on formula as a novel food pursuant to Regulation (EU) 2015/2283’ (4) in accordance with Article 11 of Regulation (EU) 2015/2283.

(6) In its scientific opinion, the Authority concluded that the novel food, oil produced from the strain CABIO-A-2 of the microalgae

Schizochytrium

sp., is safe under the proposed conditions of use. The Authority noted, that as the proposed use levels are in accordance with Regulation (EU) No 609/2013 and its supplementing Commission Delegated Regulation (EU) 2016/127 (5), the intake of docosahexaenoic acid (DHA) from infant formula and follow on formula containing the novel food at the proposed use levels is within the range foreseen by that Regulation. Therefore, that scientific opinion gives sufficient grounds to establish that

Schizochytrium

sp. (CABIO-A-2) oil, when used under the proposed conditions of use, fulfils the conditions for its placing on the market in accordance with Article 12(1) of Regulation (EU) 2015/2283. It is appropriate that the inclusion of

Schizochytrium

sp. (CABIO-A-2) oil as a novel food in the Union list of novel foods contains the information referred to in Article 9(3) of Regulation (EU) 2015/2283.

(7) Schizochytrium

sp. (CABIO-A-2) oil should be included in the Union list of novel foods set out in Implementing Regulation (EU) 2017/2470. The Annex to Implementing Regulation (EU) 2017/2470 should therefore be amended accordingly.

(8) The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed,

HAS ADOPTED THIS REGULATION:

Article 1

(1)

Schizochytrium

sp. (CABIO-A-2) oil is authorised to be placed on the market within the Union.

Schizochytrium

sp. (CABIO-A-2) oil shall be included in the Union list of novel foods set out in Implementing Regulation (EU) 2017/2470.

(2) The Annex to Implementing Regulation (EU) 2017/2470 is amended in accordance with the Annex to this Regulation.

Article 2

This Regulation shall enter into force on the twentieth day following that of its publication in

the Official Journal of the European Union.

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 30 July 2024.

For the Commission

The President

Ursula VON DER LEYEN

(1)

OJ L 327, 11.12.2015, p. 1

, ELI:

http://data.europa.eu/eli/reg/2015/2283/oj

(2) Commission Implementing Regulation (EU) 2017/2470 of 20 December 2017 establishing the Union list of novel foods in accordance with Regulation (EU) 2015/2283 of the European Parliament and of the Council on novel foods (

OJ L 351, 30.12.2017, p. 72

, ELI:

http://data.europa.eu/eli/reg_impl/2017/2470/oj

(3) Regulation (EU) No 609/2013 of the European Parliament and of the Council of 12 June 2013 on food intended for infants and young children, food for special medical purposes, and total diet replacement for weight control and repealing Council Directive 92/52/EEC, Commission Directives 96/8/EC, 1999/21/EC, 2006/125/EC and 2006/141/EC, Directive 2009/39/EC of the European Parliament and of the Council and Commission Regulations (EC) No 41/2009 and (EC) No 953/2009 (

OJ L 181, 29.6.2013, p. 35

, ELI:

http://data.europa.eu/eli/reg/2013/609/oj

(4)

EFSA Journal

. 2023;21:e8415.

(5) Commission Delegated Regulation (EU) 2016/127 of 25 September 2015 supplementing Regulation (EU) No 609/2013 of the European Parliament and of the Council as regards the specific compositional and information requirements for infant formula and follow-on formula and as regards requirements on information relating to infant and young child feeding (

OJ L 25, 2.2.2016, p. 1

, ELI:

http://data.europa.eu/eli/reg_del/2016/127/oj

ANNEX

The Annex to Implementing Regulation (EU) 2017/2470 is amended as follows:

(1) in Table 1 (Authorised novel foods), the following entry is inserted:

Authorised novel food	Conditions under which the novel food may be used		Additional specific labelling requirements	Other requirements	Data protection
‘ Schizochytrium sp. (CABIO-A-2) oil	Specified food category	Maximum levels of DHA	The designation of the novel food on the labelling of the foodstuffs containing it shall be “Oil from the microalgae Schizochytrium sp.”.’
	Infant formula and follow-on formula as defined in Regulation (EU) No 609/2013	In accordance with Regulation (EU) No 609/2013

(2) in Table 2 (Specifications), the following entry is inserted:

Authorised Novel Food

Specification

‘ Schizochytrium sp. (CABIO-A-2) oil

Description/Definition:

The novel food is an oil produced from the strain CABIO-A-2 of the microalgae Schizochytrium sp.

Composition:

DHA content: ≥ 35,0 %

Acid value: ≤ 0,5 mg KOH/g

Peroxide value: ≤ 5,0 meq/kg

Moisture and volatiles: ≤ 0,05 %

Unsaponifiables: ≤ 3,5 %

Trans-fatty acids: ≤ 2,0 %

Free fatty acids: ≤ 0,4 %

p-Anisidine value: ≤ 10’

ELI: http://data.europa.eu/eli/reg_impl/2024/2101/oj

ISSN 1977-0677 (electronic edition)